Julien Viotti Selected Research

Voltage-Dependent Anion Channels

1/2020

Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julien Viotti Research Topics

Disease

4	Neoplasms (Cancer) 01/2020 - 05/2013
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 09/2017
1	COVID-19 12/2022
1	Pneumonia (Pneumonitis) 12/2022
1	Oropharyngeal Neoplasms 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Hemorrhage 10/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Parkinson Disease (Parkinson's Disease) 05/2013

Drug/Important Bio-Agent (IBA)

3	Sunitinib (Sutent)FDA Link 01/2019 - 09/2017
1	avdoralimabIBA 12/2022
1	CreatinineIBA 10/2020
1	Dabigatran FDA Link 10/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	atezolizumabIBA 01/2020
1	Voltage-Dependent Anion ChannelsIBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2019
1	pertuzumabIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 05/2013
1	Carrier Proteins (Binding Protein)IBA 05/2013

Therapy/Procedure

3	Radiotherapy 01/2021 - 01/2020